Overview

A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

Status:
Completed

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

A Randomized Phase II study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation alone in Resected High-Risk Malignant Salivary Gland Tumors

Phase:

Phase 2

Details

Lead Sponsor:

King Faisal Specialist Hospital & Research Center

Collaborator:

Radiation Therapy Oncology Group

Treatments:

Cisplatin